7231 - 7240 of 8620 Results
Title
Year
- Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult mice2021OPENTitle: Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult miceJournal Name: Transgenic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 867End Page: 873Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11248-021-00286-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11248-021-00286-3.pdfCitation Count: 3
- Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease2022OPENTitle: Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01388-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01388-7Citation Count: 77
- LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease2022OPENTitle: LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00354-3Best OA location URL: https://www.nature.com/articles/s41531-022-00354-3.pdfCitation Count: 35
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://www.prd-journal.com/article/S1353802018304310/pdfCitation Count: 17
- Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substrates2023OPENTitle: Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substratesJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 228Issue #: 3-4Start Page: 845End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00429-023-02626-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00429-023-02626-x.pdfCitation Count: 1
- Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological Samples2023OPENTitle: Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological SamplesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 7Start Page: 1238End Page: 1248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00676Best OA location URL: https://escholarship.org/uc/item/0042q8vmCitation Count: 23
- Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease2018OPENTitle: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 26Issue #: 2Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13797Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6329649Citation Count: 50
-
OPENTitle: Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or SeverityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 190End Page: 195Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28792Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9292990Citation Count: 27
- Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease2020OPENTitle: Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 963End Page: 976Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28424Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28424Citation Count: 51
-
OPENTitle: Levodopa Impairs the Energy Metabolism of the Basal Ganglia In VivoJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 5Start Page: 849End Page: 857Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26884Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26884Citation Count: 7